Sarah M. Lima, PhD, MPH, on how historical redlining continues to shape breast cancer survival disparities through treatment access and innovation.
Sarah M. Lima, PhD, MPH
Advertisement
Sarah M. Lima, PhD, MPH, is an epidemiologist and postdoctoral fellow in cancer population at the Georgetown Lombardi Comprehensive Cancer Center.
Articles by Sarah M. Lima, PhD, MPH
Study finds breast cancer survival gaps tied to historical redlining narrowed over time, though newer therapies may be widening disparities again.
Advertisement
Latest Updated Articles
Redlining Linked to Breast Cancer Survival Gaps: Sarah M. Lima, PhD, MPHFebruary 13th 2026
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves First Oral Carbapenem Antibiotic for Complicated UTIs
2
Fourteen Years of HIV PrEP: How New Innovations Build on Decades of Progress in HIV
3
Oral COVID-19 PEP May Benefit High-Risk Groups More Than General Public: Peter J. Hotez, MD
4
Study Finds Flaw in Method for Key Oncology Value-Based Care Model
5